Primary systemic amyloidosis
RL Comenzo - Current Treatment Options in Oncology, 2000 - Springer
Opinion statement Patients with unexplained heart failure, hepatomegaly, nephrotic
syndrome, or peripheral neuropathy should be evaluated for primary systemic (amyloid …
syndrome, or peripheral neuropathy should be evaluated for primary systemic (amyloid …
Primary systemic amyloidosis.
RL Comenzo - Current Treatment Options in Oncology, 2000 - europepmc.org
Patients with unexplained heart failure, hepatomegaly, nephrotic syndrome, or peripheral
neuropathy should be evaluated for primary systemic (amyloid light-chain, or AL) …
neuropathy should be evaluated for primary systemic (amyloid light-chain, or AL) …
Primary systemic amyloidosis
RL Comenzo - Current Treatment Options in Oncology, 2000 - search.proquest.com
Patients with unexplained heart failure, hepatomegaly, nephrotic syndrome, or peripheral
neuropathy should be evaluated for primary systemic (amyloid lightchain, or AL) amyloidosis …
neuropathy should be evaluated for primary systemic (amyloid lightchain, or AL) amyloidosis …
Primary systemic amyloidosis
RL Comenzo - Current treatment options in oncology, 2000 - pubmed.ncbi.nlm.nih.gov
Patients with unexplained heart failure, hepatomegaly, nephrotic syndrome, or peripheral
neuropathy should be evaluated for primary systemic (amyloid light-chain, or AL) …
neuropathy should be evaluated for primary systemic (amyloid light-chain, or AL) …
Primary systemic amyloidosis
RL Comenzo - Current Treatment Options in Oncology, 2000 - infona.pl
Opinion statement Patients with unexplained heart failure, hepatomegaly, nephrotic
syndrome, or peripheral neuropathy should be evaluated for primary systemic (amyloid …
syndrome, or peripheral neuropathy should be evaluated for primary systemic (amyloid …